December 5, 2012
Hercules, CA —— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today provided an update to its November 5th announcement that the company was awarded a three-year sole source group purchasing contract for its blood bank reagents from the Premier healthcare alliance. Bio-Rad [...]
December 4, 2012
Torrance, CA - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the extension of its Chiral Screening Service to pharmaceutical and natural products customers in China. The service is offered in collaboration with the Chinese Academy of Sciences (CAS), a leading academic and R&D center [...]
StemSpan™ SFEM II, for unparalleled hematopoietic cell expansion performance.
December 4, 2012
STEMCELL Technologies Inc. announced this week the launch of StemSpan™ SFEM II, a new hematopoietic stem cell expansion medium for maximum expansion of CD34+ cells from human cord blood and bone marrow. StemSpan™ SFEM II provides on average 40% higher expansion of hematopoietic progenitors compared to six leading commercially available serum-free media from different suppliers. [...]
Neogen launches improved rapid test for Salmonella Enteritidis
December 4, 2012
LANSING, Mich., — Neogen Corporation has signi? cantly improved its Reveal® rapid lateral ? ow test for Salmonella enterica serovar Enteritidis, and has launched the improved test as Reveal 2.0 for Salmonella Enteritidis. The improved test for Salmonella Enteritidis (SE) provides results in only 10 minutes after a 48-hour sample enrichment. Unlike other rapid tests [...]
Scharlau Science Group acquires Bibby Scientific Italy
December 4, 2012
Scharlau Science Group, announces the acquisition of all the shares of the distribution company Bibby Scientific Italy from the firm Nova Capital Management Ltd. Nova Capital Management Ltd., a firm specialized in the sales-purchases of companies, acquired in 2007 the South African scientific division Barlow World Group. One of the companies belonging to the scientific [...]
VWR International, LLC Expands European Portfolio With Acquisitions of Labonord SAS and Switch BVBA
December 4, 2012
RADNOR, PA, - VWR International, LLC, a leading global laboratory supply and distribution company, announced today that it has acquired Labonord SAS and Switch BVBA, expanding the company's cytology and histology portfolio in Europe. Based in Lille, France, Labonord is an independent supplier of consumables and chemicals and also represents a number of leading suppliers [...]
BioCision Raises $2.5 Million Growth Financing to Support Continued Expansion
December 4, 2012
LARKSPUR, Calif. -- BioCision LLC, a developer of sample standardization tools and solutions for the life science research and clinical markets, today announced it has raised $2.5 million in new growth financing. The round was led by BroadOak Capital Partners and included participation from Research Corporation Technologies, Inc. Comprised of debt and equity investment, funding [...]
December 3, 2012
Grenoble, France, – CYTOO S.A., a life science systems & tools company that offers disruptive solutions for cell-based assays and High Content Screening (HCS), will launch the CYTOOplates Motility, based on CYTOO’s 2D+ Cell Culture Platform with its adhesive micropatterns, at the ASCB 2012 Annual meeting in San Francisco, USA. After sponsoring last year’s “World [...]
FEI QEMSCAN WellSite Expands to Onsite Core Analysis With System Delivery to Kirk Petrophysics
December 3, 2012
HILLSBORO, Ore. and SURREY, England, -- FEI (Nasdaq:FEIC) and Kirk Petrophysics (Surrey, U.K.) today announced that FEI has delivered a QEMSCAN® WellSite™ analysis system to Kirk Petrophysics, who will use it to provide rapid onsite analysis of drill cores in oil and gas drilling operations. Core analysis is an essential component of formation evaluation used [...]
NanoString Technologies Completes $15.3 Million Series E Financing
December 3, 2012
SEATTLE, Wash. – NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced the completion of a $15.3 million Series E Preferred Stock issuance. New investors in the transaction included Morgan Stanley Expansion Capital and AllianceBernstein Alternative Investment Management Group. All previous venture [...]

